全球止血和组织密封剂市场规模、份额、趋势和成长分析报告（2026-2034年）

预计止血和组织黏合剂市场将从 2025 年的 63.4 亿美元成长到 2034 年的 141.7 亿美元，2026 年至 2034 年的复合年增长率为 9.34%。

受全球外科手术数量不断增加的推动，全球止血剂和组织黏合剂市场正经历强劲成长。这些产品广泛用于术中止血、组织黏合和促进创伤治疗。它们常用于心血管外科、整形外科、神经外科和普通外科手术，以改善手术效果并减少併发症。

外科产品和生物材料的技术进步在市场发展中发挥着至关重要的作用。现代止血剂和密封剂旨在实现快速凝血和改善组织黏附。这些产品正日益受到外科医生的青睐，因为它们有助于最大限度地减少出血、缩短手术时间并加速患者康復。

随着全球对微创手术的需求持续成长，预计市场将进一步扩大。新兴国家医疗基础设施的改善和手术数量的增加也促进了市场扩张。生物相容性材料和手术技术的不断创新将支持该领域的长期发展。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球止血与组织密封剂市场：依产品分类

• 市场分析、洞察与预测
• 局部止血剂
• 黏合剂和组织密封胶
• 防沾黏产品

第五章 全球止血与组织密封剂市场：依材料分类

• 市场分析、洞察与预测
• 明胶局部止血剂
• 胶原蛋白局部止血剂
• 基于ORC的局部止血剂
• 基于多醣的局部止血剂

第六章 全球止血与组织密封剂市场：依应用领域划分

• 市场分析、洞察与预测
• 一般外科
• 神经外科
• 血管外科
• 心血管外科
• 其他的

第七章 全球止血与组织密封剂市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 其他的

第八章 全球止血与组织密封剂市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Johnson & Johnson
  • CryoLife Inc
  • Advance Medical Solution（AMS）Group Plc
  • Cohera Medical Inc
  • Integra Life Sciences Corporation
  • Pfizer Inc
  • BD
  • Cohesion Technologies Inc
  • HyperBranch Medical Technology
  • Biomet Inc
  • Braun Medical Inc
  • Smith & Nephew

The Hemostasis and Tissue Sealing Agents Market size is expected to reach USD 14.17 Billion in 2034 from USD 6.34 Billion (2025) growing at a CAGR of 9.34% during 2026-2034.

The global hemostasis and tissue sealing agents market is experiencing strong growth due to the rising number of surgical procedures performed worldwide. These agents are widely used to control bleeding, seal tissues, and enhance wound healing during surgeries. They are commonly applied in cardiovascular, orthopedic, neurological, and general surgical procedures to improve surgical outcomes and reduce complications.

Technological advancements in surgical products and biomaterials are playing a key role in market development. Modern hemostatic agents and sealants are designed to provide rapid clot formation and improved tissue adhesion. Surgeons increasingly prefer these products as they help minimize blood loss, reduce surgical time, and improve patient recovery.

The market is expected to grow further as the demand for minimally invasive surgeries continues to rise globally. Increasing healthcare infrastructure development and growing surgical volumes in emerging economies are also contributing to market expansion. Continuous innovation in biocompatible materials and surgical technologies will support long-term growth in this sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Topical Hemostat
• Adhesive & Tissue Sealant
• Adhesion Barrier Products

By Material

• Gelatin-Based Topical Hemostats
• Collagen-Based Topical Hemostats
• ORC-Based Topical Hemostats
• Polysaccharide-Based Topical Hemostats

By Application

• General Surgery
• Neurosurgery
• Vascular Surgery
• Cardiovascular Surgery
• Others

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Johnson Johnson, CryoLife Inc, Advance Medical Solution AMS Group Plc, Cohera Medical Inc, Integra Life Sciences Corporation, Pfizer Inc, BD, Cohesion Technologies Inc, HyperBranch Medical Technology, Biomet Inc, Braun Medical Inc, Smith Nephew
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Topical Hemostat Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Adhesive & Tissue Sealant Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Adhesion Barrier Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: BY MATERIAL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material
• 5.2. Gelatin-Based Topical Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Collagen-Based Topical Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. ORC-Based Topical Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Polysaccharide-Based Topical Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. General Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Neurosurgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Vascular Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cardiovascular Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Material
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Material
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Material
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Material
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Material
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Johnson & Johnson
  • 10.2.2 CryoLife Inc
  • 10.2.3 Advance Medical Solution (AMS) Group Plc
  • 10.2.4 Cohera Medical Inc
  • 10.2.5 Integra Life Sciences Corporation
  • 10.2.6 Pfizer Inc
  • 10.2.7 BD
  • 10.2.8 Cohesion Technologies Inc
  • 10.2.9 HyperBranch Medical Technology
  • 10.2.10 Biomet Inc
  • 10.2.11 Braun Medical Inc
  • 10.2.12 Smith & Nephew